Thomas Phd Adams, EC, Director at Cardiff Oncology, holds 18.88K shares in Cardiff Oncology (Ticker: CRDF), holds ― shares in Hepion Pharmaceuticals (Ticker: HEPA), holds 72.24K shares in Synergy Pharmaceuticals Inc (Ticker: SGYPQ). Most recently, Thomas Phd Adams Bought ― shares of Cardiff Oncology on May 18, 2020 for an estimated value of 20.00K.
What is the percentage of profitable transactions made by Thomas Phd Adams?
The percentage of profitable transactions made by Thomas Phd Adams is 100%.
What is the average return per transaction made by Thomas Phd Adams?
The average return per transaction made by Thomas Phd Adams is 412.50%.
What stocks does Thomas Phd Adams hold?
Thomas Phd Adams holds: CRDF, HEPA, SGYPQ, LJPC stocks.
What was Thomas Phd Adams’s latest transaction?
Thomas Phd Adams latest transaction was an Informative Buy of $20.00K.
What was Thomas Phd Adams's most profitable transaction?
Thomas Phd Adams’s most profitable transaction was an Informative Buy of CRDF stock on May 18, 2020. The return on the trade was 800.00%.
What is Thomas Phd Adams's role in Cardiff Oncology?
Thomas Phd Adams's role in Cardiff Oncology is EC, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.